FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Vet Res Commun / Equine adipose-tissue derived mesenchymal stem cells and pla...
Veterinary research communications2008; 32 Suppl 1; S51-S55; doi: 10.1007/s11259-008-9093-3

Equine adipose-tissue derived mesenchymal stem cells and platelet concentrates: their association in vitro and in vivo.

Abstract: Equine mesenchymal stem cells (MSC) are of particular interest both for basic research and for the therapeutic approach to musculoskeletal diseases in the horse. Their multilineage differentiation potential gives them the capability to contribute to the repair of tendon, ligament and bone damage. MSCs are also considered a promising therapeutic aid in allogeneic cell transplantation, since they show low immunogenicity and immunomodulating functions.Adipose tissue-derived adult equine stem cells (AdMSC) can be isolated, expanded in vitro and then inoculated into the damaged tissue, eventually in the presence of a biological scaffold. Here we report our preliminary experience with adipose-derived mesenchymal stem cells in allogeneic cell-therapy of tendonitis in the horse. MSCs, derived from visceral adipose tissue, were grown in the presence of autologous platelet lysate and characterized for their differentiation and growth potential. Expanded AdMSC were inoculated into the damaged tendon after their dispersion in activated platelet-rich plasma (PRP), a biological scaffold that plays an important role in maintaining cells in defect sites and contributes to tissue healing. Fourteen out of sixteen treated horses showed a functional recovery and were able to return to their normal activity.
Get Full Text
Publication Date: 2008-08-07 PubMed ID: 18683070DOI: 10.1007/s11259-008-9093-3Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study investigates the potential of using fat-derived stem cells and platelet concentrates in the treatment of tendonitis in horses. The researchers cultivated these stem cells with a platelet solution, then introduced this mixture into the affected area. The promising results suggest this approach could offer a functional recovery for horses with tendonitis.

Context and Objectives

  • The researchers are interested in equine mesenchymal stem cells (MSC). These cells are versatile, able to transform into various other cells types. They are of immense interest for treating musculoskeletal diseases in horses, given their potential to fix damage to tendons, ligaments, and bone.
  • Adipose tissue-derived mesenchymal stem cells (AdMSC) are stem cells derived from fat tissue. They are known for their low immune response, meaning they can be transplanted to other individuals without triggering a strong immune reaction.
  • The aim of this study was to examine the use of adipose-derived MSCs in the treatment of tendonitis in horses, by transmuting these MSCs in autologous platelet lysate. This solution helps to stimulate cell growth and differentiation.

Methodology

  • The MSCs were harvested from horse visceral fat tissue, expanded in autologous platelet lysate, and characterized based on their growth and differentiation potential.
  • The expanded AdMSCs were then injected into the tendon suffering from tendonitis.
  • To enhance the placement and function of these stem cells, they were dispersed in activated platelet-rich plasma (PRP). PRP serves as a biological scaffold, guiding and supporting cell growth in specific locations.

Results and Conclusion

  • The results were promising, with 14 out of 16 treated horses showing functional recovery and returning to their normal activity.
  • These findings present adipose-derived MSCs and PRP as a potential therapeutic solution for tendonitis in horses.
  • Further research is needed to fully understand and optimize this potential treatment pathway.

Cite This Article

APA
Del Bue M, Riccò S, Ramoni R, Conti V, Gnudi G, Grolli S. (2008). Equine adipose-tissue derived mesenchymal stem cells and platelet concentrates: their association in vitro and in vivo. Vet Res Commun, 32 Suppl 1, S51-S55. https://doi.org/10.1007/s11259-008-9093-3

Publication

Veterinary research communications
ISSN: 1573-7446
NlmUniqueID: 8100520
Country: Switzerland
Language: English
Volume: 32 Suppl 1
Pages: S51-S55

Researcher Affiliations

Del Bue, M
  • Department of Animal Health, Veterinary Biotechnology, Food Quality and Safety, University of Parma, via del Taglio 8, Parma 43100, Italy.
Riccò, S
    Ramoni, R
      Conti, V
        Gnudi, G
          Grolli, S

            MeSH Terms

            • Adipose Tissue / cytology
            • Adipose Tissue / physiology
            • Animals
            • Cell Transplantation / methods
            • Cell Transplantation / veterinary
            • Horse Diseases / surgery
            • Horses / blood
            • Horses / physiology
            • Mesenchymal Stem Cell Transplantation / methods
            • Mesenchymal Stem Cell Transplantation / veterinary
            • Mesenchymal Stem Cells / cytology
            • Mesenchymal Stem Cells / physiology
            • Platelet Count
            • Platelet-Rich Plasma
            • Tendinopathy / surgery
            • Tendinopathy / veterinary
            • Tissue Engineering / methods
            • Tissue Engineering / veterinary
            • Transplantation, Homologous
            • Treatment Outcome

            References

            This article includes 9 references
            1. Vet Res Commun. 2007 Aug;31 Suppl 1:281-3
              pubmed: 17682895
            2. Ital J Biochem. 1983 Sep-Oct;32(5):297-305
              pubmed: 6662668
            3. Trends Biotechnol. 2007 Sep;25(9):409-16
              pubmed: 17692415
            4. Sports Med. 2003;33(5):381-94
              pubmed: 12696985
            5. Thromb J. 2006 Sep 28;4:18
              pubmed: 17005053
            6. Ann N Y Acad Sci. 2007 Nov;1117:310-27
              pubmed: 18056051
            7. J Bone Joint Surg Am. 2007 Jan;89(1):74-81
              pubmed: 17200313
            8. Blood. 2007 Nov 15;110(10):3499-506
              pubmed: 17664353
            9. Vet Res Commun. 2007 Aug;31 Suppl 1:289-92
              pubmed: 17682897

            Citations

            This article has been cited 37 times.
            1. Merhi Z. Clinical practice perspectives on adipose-derived stem cells and platelet-rich plasma for female infertility treatments. Future Sci OA 2025 Dec;11(1):2580233.
              doi: 10.1080/20565623.2025.2580233pubmed: 41160570google scholar: lookup
            2. Carmona JU, Carmona-Ramírez LH, López C. Platelet-Rich Plasma and Related Orthobiologics for the Treatment of Equine Musculoskeletal Disorders-A Bibliometric Analysis from 2000 to 2024. Vet Sci 2024 Aug 21;11(8).
              doi: 10.3390/vetsci11080385pubmed: 39195839google scholar: lookup
            3. Carlier S, Depuydt E, Van Hecke L, Martens A, Saunders J, Spaas JH. Safety assessment of equine allogeneic tenogenic primed mesenchymal stem cells in horses with naturally occurring tendon and ligament injuries. Front Vet Sci 2024;11:1282697.
              doi: 10.3389/fvets.2024.1282697pubmed: 38468694google scholar: lookup
            4. Doll CU, Niebert S, Burk J. Mesenchymal Stromal Cells Adapt to Chronic Tendon Disease Environment with an Initial Reduction in Matrix Remodeling. Int J Mol Sci 2021 Nov 26;22(23).
              doi: 10.3390/ijms222312798pubmed: 34884602google scholar: lookup
            5. Ribitsch I, Oreff GL, Jenner F. Regenerative Medicine for Equine Musculoskeletal Diseases. Animals (Basel) 2021 Jan 19;11(1).
              doi: 10.3390/ani11010234pubmed: 33477808google scholar: lookup
            6. Bukowska J, Szóstek-Mioduchowska AZ, Kopcewicz M, Walendzik K, Machcińska S, Gawrońska-Kozak B. Adipose-Derived Stromal/Stem Cells from Large Animal Models: from Basic to Applied Science. Stem Cell Rev Rep 2021 Jun;17(3):719-738.
              doi: 10.1007/s12015-020-10049-ypubmed: 33025392google scholar: lookup
            7. Mocchi M, Dotti S, Bue MD, Villa R, Bari E, Perteghella S, Torre ML, Grolli S. Veterinary Regenerative Medicine for Musculoskeletal Disorders: Can Mesenchymal Stem/Stromal Cells and Their Secretome Be the New Frontier?. Cells 2020 Jun 11;9(6).
              doi: 10.3390/cells9061453pubmed: 32545382google scholar: lookup
            8. Bourebaba L, Bedjou F, Röcken M, Marycz K. Nortropane alkaloids as pharmacological chaperones in the rescue of equine adipose-derived mesenchymal stromal stem cells affected by metabolic syndrome through mitochondrial potentiation, endoplasmic reticulum stress mitigation and insulin resistance alleviation. Stem Cell Res Ther 2019 Jun 18;10(1):178.
              doi: 10.1186/s13287-019-1292-zpubmed: 31215461google scholar: lookup
            9. Kornicka K, Geburek F, Röcken M, Marycz K. Stem Cells in Equine Veterinary Practice-Current Trends, Risks, and Perspectives. J Clin Med 2019 May 14;8(5).
              doi: 10.3390/jcm8050675pubmed: 31091732google scholar: lookup
            10. Smieszek A, Kornicka K, Szłapka-Kosarzewska J, Androvic P, Valihrach L, Langerova L, Rohlova E, Kubista M, Marycz K. Metformin Increases Proliferative Activity and Viability of Multipotent Stromal Stem Cells Isolated from Adipose Tissue Derived from Horses with Equine Metabolic Syndrome. Cells 2019 Jan 22;8(2).
              doi: 10.3390/cells8020080pubmed: 30678275google scholar: lookup
            11. Norelli JB, Plaza DP, Stal DN, Varghese AM, Liang H, Grande DA. Tenogenically differentiated adipose-derived stem cells are effective in Achilles tendon repair in vivo. J Tissue Eng 2018 Jan-Dec;9:2041731418811183.
              doi: 10.1177/2041731418811183pubmed: 30542597google scholar: lookup
            12. Bigliardi E, Cantoni AM, De Cesaris V, Denti L, Conti V, Bertocchi M, Di Ianni F, Parmigiani E, Grolli S. Use of platelet-rich plasma for the treatment of prostatic cysts in dogs. Can J Vet Res 2018 Oct;82(4):264-270.
              pubmed: 30363366
            13. de Aro AA, Carneiro GD, Teodoro LFR, da Veiga FC, Ferrucci DL, Simões GF, Simões PW, Alvares LE, de Oliveira ALR, Vicente CP, Gomes CP, Pesquero JB, Esquisatto MAM, de Campos Vidal B, Pimentel ER. Injured Achilles Tendons Treated with Adipose-Derived Stem Cells Transplantation and GDF-5. Cells 2018 Aug 31;7(9).
              doi: 10.3390/cells7090127pubmed: 30200326google scholar: lookup
            14. Sultana T, Lee S, Yoon HY, Lee JI. Current Status of Canine Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Veterinary Medicine. Stem Cells Int 2018;2018:8329174.
              doi: 10.1155/2018/8329174pubmed: 30123294google scholar: lookup
            15. Barboni B, Russo V, Berardinelli P, Mauro A, Valbonetti L, Sanyal H, Canciello A, Greco L, Muttini A, Gatta V, Stuppia L, Mattioli M. Placental Stem Cells from Domestic Animals: Translational Potential and Clinical Relevance. Cell Transplant 2018 Jan;27(1):93-116.
              doi: 10.1177/0963689717724797pubmed: 29562773google scholar: lookup
            16. Beerts C, Suls M, Broeckx SY, Seys B, Vandenberghe A, Declercq J, Duchateau L, Vidal MA, Spaas JH. Tenogenically Induced Allogeneic Peripheral Blood Mesenchymal Stem Cells in Allogeneic Platelet-Rich Plasma: 2-Year Follow-up after Tendon or Ligament Treatment in Horses. Front Vet Sci 2017;4:158.
              doi: 10.3389/fvets.2017.00158pubmed: 29018808google scholar: lookup
            17. Wang X, Liu C, Xu Y, Chen P, Shen Y, Xu Y, Zhao Y, Chen W, Zhang X, Ouyang Y, Wang Y, Xie C, Zhou M, Liu C. Combination of mesenchymal stem cell injection with icariin for the treatment of diabetes-associated erectile dysfunction. PLoS One 2017;12(3):e0174145.
              doi: 10.1371/journal.pone.0174145pubmed: 28350842google scholar: lookup
            18. Marycz K, Kornicka K, Marędziak M, Golonka P, Nicpoń J. Equine metabolic syndrome impairs adipose stem cells osteogenic differentiation by predominance of autophagy over selective mitophagy. J Cell Mol Med 2016 Dec;20(12):2384-2404.
              doi: 10.1111/jcmm.12932pubmed: 27629697google scholar: lookup
            19. Griffon DJ, Cho J, Wagner JR, Charavaryamath C, Wei J, Wagoner Johnson A. Effects of Hypoxia and Chitosan on Equine Umbilical Cord-Derived Mesenchymal Stem Cells. Stem Cells Int 2016;2016:2987140.
              doi: 10.1155/2016/2987140pubmed: 27379167google scholar: lookup
            20. Yu Y, Zhou Y, Cheng T, Lu X, Yu K, Zhou Y, Hong J, Chen Y. Hypoxia enhances tenocyte differentiation of adipose-derived mesenchymal stem cells by inducing hypoxia-inducible factor-1α in a co-culture system. Cell Prolif 2016 Apr;49(2):173-84.
              doi: 10.1111/cpr.12250pubmed: 27021233google scholar: lookup
            21. Carr BJ, Canapp SO Jr, Mason DR, Cox C, Hess T. Canine Platelet-Rich Plasma Systems: A Prospective Analysis. Front Vet Sci 2015;2:73.
              doi: 10.3389/fvets.2015.00073pubmed: 26779493google scholar: lookup
            22. Arnhold S, Wenisch S. Adipose tissue derived mesenchymal stem cells for musculoskeletal repair in veterinary medicine. Am J Stem Cells 2015;4(1):1-12.
              pubmed: 25973326
            23. Sun HB, Schaniel C, Leong DJ, Wang JH. Biology and mechano-response of tendon cells: Progress overview and perspectives. J Orthop Res 2015 Jun;33(6):785-92.
              doi: 10.1002/jor.22885pubmed: 25728946google scholar: lookup
            24. Marędziak M, Marycz K, Lewandowski D, Siudzińska A, Śmieszek A. Static magnetic field enhances synthesis and secretion of membrane-derived microvesicles (MVs) rich in VEGF and BMP-2 in equine adipose-derived stromal cells (EqASCs)-a new approach in veterinary regenerative medicine. In Vitro Cell Dev Biol Anim 2015 Mar;51(3):230-40.
              doi: 10.1007/s11626-014-9828-0pubmed: 25428200google scholar: lookup
            25. Marędziak M, Marycz K, Smieszek A, Lewandowski D, Toker NY. The influence of static magnetic fields on canine and equine mesenchymal stem cells derived from adipose tissue. In Vitro Cell Dev Biol Anim 2014 Jun;50(6):562-71.
              doi: 10.1007/s11626-013-9730-1pubmed: 24477562google scholar: lookup
            26. Carvalho Ade M, Badial PR, Álvarez LE, Yamada AL, Borges AS, Deffune E, Hussni CA, Garcia Alves AL. Equine tendonitis therapy using mesenchymal stem cells and platelet concentrates: a randomized controlled trial. Stem Cell Res Ther 2013 Jul 22;4(4):85.
              doi: 10.1186/scrt236pubmed: 23876512google scholar: lookup
            27. Carrade DD, Borjesson DL. Immunomodulation by mesenchymal stem cells in veterinary species. Comp Med 2013 Jun;63(3):207-17.
              pubmed: 23759523
            28. Ruzzini L, Longo UG, Rizzello G, Denaro V. Stem cells and tendinopathy: state of the art from the basic science to clinic application. Muscles Ligaments Tendons J 2012 Jul;2(3):235-8.
              pubmed: 23738302
            29. Tetta C, Consiglio AL, Bruno S, Tetta E, Gatti E, Dobreva M, Cremonesi F, Camussi G. The role of microvesicles derived from mesenchymal stem cells in tissue regeneration; a dream for tendon repair?. Muscles Ligaments Tendons J 2012 Jul;2(3):212-21.
              pubmed: 23738299
            30. Fontenot RL, Sink CA, Werre SR, Weinstein NM, Dahlgren LA. Simple tube centrifugation for processing platelet-rich plasma in the horse. Can Vet J 2012 Dec;53(12):1266-72.
              pubmed: 23729823
            31. Volk SW, Theoret C. Translating stem cell therapies: the role of companion animals in regenerative medicine. Wound Repair Regen 2013 May-Jun;21(3):382-94.
              doi: 10.1111/wrr.12044pubmed: 23627495google scholar: lookup
            32. Spaas JH, Guest DJ, Van de Walle GR. Tendon regeneration in human and equine athletes: Ubi Sumus-Quo Vadimus (where are we and where are we going to)?. Sports Med 2012 Oct 1;42(10):871-90.
              doi: 10.1007/BF03262300pubmed: 22963225google scholar: lookup
            33. Young M. Stem cell applications in tendon disorders: a clinical perspective. Stem Cells Int 2012;2012:637836.
              doi: 10.1155/2012/637836pubmed: 22448174google scholar: lookup
            34. Mensing N, Gasse H, Hambruch N, Haeger JD, Pfarrer C, Staszyk C. Isolation and characterization of multipotent mesenchymal stromal cells from the gingiva and the periodontal ligament of the horse. BMC Vet Res 2011 Aug 2;7:42.
              doi: 10.1186/1746-6148-7-42pubmed: 21810270google scholar: lookup
            35. Schwarz C, Leicht U, Drosse I, Ulrich V, Luibl V, Schieker M, Röcken M. Characterization of adipose-derived equine and canine mesenchymal stem cells after incubation in agarose-hydrogel. Vet Res Commun 2011 Dec;35(8):487-99.
              doi: 10.1007/s11259-011-9492-8pubmed: 21755422google scholar: lookup
            36. Raabe O, Shell K, Würtz A, Reich CM, Wenisch S, Arnhold S. Further insights into the characterization of equine adipose tissue-derived mesenchymal stem cells. Vet Res Commun 2011 Aug;35(6):355-65.
              doi: 10.1007/s11259-011-9480-zpubmed: 21614641google scholar: lookup
            37. Torricelli P, Fini M, Filardo G, Tschon M, Pischedda M, Pacorini A, Kon E, Giardino R. Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses. Int Orthop 2011 Oct;35(10):1569-76.
              doi: 10.1007/s00264-011-1237-3pubmed: 21394594google scholar: lookup
            Subscribe to our newsletter
            Join 99,048 horse owners like you who receive our email updates on horse health and nutrition.